Skip to main content

Advertisement

Table 2 The clinical, biochemical and laboratory data of 60 patients

From: Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways

Characterize Control Patients P
Gender (M/F) 3/4 25/28 > 0.05
Age (years) 29.2 ± 9.9 30.1 ± 10.2 > 0.05
Liver inflammation (G :1/2/3/4) 5/2/0/0 4/16/23/10  
Liver fibrosis (S: 1/2/3/4) 4/3/0/0 6/18/20/9  
ALT (IU/l) 21.2 ± 10.2 64 ± 21.1 < 0.05
AST (IU/l) 18.8 ± 8.3 51.3 ± 9.8 < 0.05
Total bilirubin (μmol/l) 7.2 ± 2.3 27.8 ± 11.1 < 0.05
Albumin (g/l) 48.1 ± 15.3 36.3 ± 12.6 < 0.05
HBV DNA (log copy/ml) 0 4.7 ± 1.5 < 0.05